• RIC Responds to FDA Request for Comments on "Changes to Third-Party Vendors"

our mission

The REMS Industry Consortium fosters collaboration and innovation to advance patient safety, appropriate access, and best practices in REMS related drug and biologic risk management.

RIC @ WDS

RIC is partnering with the World Drug Safety conference and is happy to offer a 50% discount to RIC members on WDS Registration.  Meet us in Boston, MA October 29th & 30th in Booth #333. 
Contact info@remsconsortium.org for more information.

member companies

  • Amneal
  • Bristol Myers Squibb
  • Jazz
  • Teva
  • Viatris
  • Apotex
  • GSK
  • MaynePharma
  • Pfizer
  • Sun Pharma
  • Zydus

This is not a complete list of RIC Members.

meet RIC

The REMS Industry Consortium is a nonprofit organization bringing together the perspectives of organizations that sell, or anticipate selling, prescription drugs or biologics subject to Risk Evaluation and Mitigation Strategies (REMS).

industry resources

The REMS Industry Consortium understands the need for REMS professionals to further develop their knowledge in the field and resources specifically tailored to them.  We are excited to announce the launch of the RIC's REMS 101 course.  The REMS 101 course was developed by REMS Industry Professionals on the RIC as a tool to be used by professionals to learn about REMS.

get involved

Join the REMS Industry Consortium to gain the knowledge, experience and professional affiliations that will put you at the forefront of REMS industry advancements.